Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04461210 · ClinicalTrials.gov registry record
Vulvodynia Pain Thresholds
A clinical trial, sponsored by State University of New York at Buffalo.
- Terminated
- Registry status
- 18
- Enrollment target
NCT04461210: Clinical Trial study, sponsored by State University of New York at Buffalo.
NCT04461210 is a clinical trial that was terminated before completion, run by State University of New York at Buffalo. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04461210 was terminated before completion, sponsored by State University of New York at Buffalo.
- TERMINATED
- Registry status
- 18 participants
- Enrollment target
Study Summary
Annotated pain maps will be created showing region and size of areas sensitive to mechanical stimulus in both women affected by vulvar pain and unaffected control patients.
Primary Outcome
Develop annotated pain maps showing region and size of area sensitive to mechanical stimulus. A cotton swab is used to lightly touch the vulva in 18 different locations and participant's assessment of pain on a scale of 0-10 is recorded.
Interventions
- DIAGNOSTIC_TEST Thermographic Imaging and Mechanical Pain Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2022-02-28 |
| Est. Completion | 2024-01-06 |
Why NCT04461210 stopped before completion
NCT04461210 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Thermographic Imaging and Mechanical Pain Assessment is the first listed.
NCT04461210 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04461210 about?
NCT04461210 is a clinical study titled "Vulvodynia Pain Thresholds". Annotated pain maps will be created showing region and size of areas sensitive to mechanical stimulus in both women affected by vulvar pain and unaffected control patients.
What is the current status of trial NCT04461210?
This trial is currently terminated. The enrollment target is 18 participants. The study started on 2022-02-28. Estimated completion is 2024-01-06.
What interventions are being tested in trial NCT04461210?
The interventions under investigation include: Thermographic Imaging and Mechanical Pain Assessment (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04461210?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI